France: Antiretroviral therapy coverage (% of people living with HIV)

Key figures

What the numbers say

In 2022, France's antiretroviral therapy coverage (% of people living with HIV) rose 1 percentage points on 2021 (from 90% to 91%).

Across the 21 yearly changes before that (2001 to 2021), the average change was +0.67 percentage points and a typical year strayed about 0.66 percentage points from that (the standard deviation). This year's change was 0.5 standard deviations above that average, so it was an ordinary year: it sits within the range of normal year-to-year movement.

On record, the biggest yearly rise was 2 percentage points in 2015 and the biggest yearly fall was 1 percentage points in 2018. The numbers show how large and when, not why; for the cause, look at what happened in that country in those years.

From 2013 to 2022 the straight-line trend is upward, about 0.25 percentage points a year. A straight line explains 42% of the movement over 10 observed years.

Worked out from the yearly values above. How the checks work: standard deviation, z-scores and straight-line trends.

How it compares

See how every economy compares in the full ranking.

Closest to France in the 2022 ranking

• Sweden — 1st of 5: 95%
• Spain — 3rd of 5: 90%
• Canada — 4th of 5: 76%
• Estonia — 5th of 5: 69%

What this measures

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.

Limitations: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information.

Regional and income-group figures are computed by the World Bank as a weighted average.

All 23 values

Antiretroviral therapy coverage (% of people living with HIV) in nearby economies

• Albania — 61% (2024)
• Armenia — 52% (2024)
• Azerbaijan — 86% (2024)
• Belgium — 88% (2023)
• Bulgaria — 62% (2024)
• Croatia — 85% (2024)
• Denmark — 92% (2023)
• Estonia — 69% (2022)
• Georgia — 72% (2024)

More health data for France

• Population ages 00-04, female (% of female population) — 4.73% (2025)
• Population ages 00-04, male (% of male population) — 5.26% (2025)
• Population ages 0-14, female — 5.45 million (2025)
• Population ages 0-14, female (% of female population) — 15.38% (2025)
• Population ages 0-14, male — 5.7 million (2025)
• Population ages 0-14, male (% of male population) — 17.12% (2025)
• Population ages 0-14, total — 11.15 million (2025)
• Population ages 0-14 (% of total population) — 16.22% (2025)
• Population ages 05-09, female (% of female population) — 5.07% (2025)

Reading data like this

• Where to find free public data, and how to check it before you trust it — 2 min read
• Data analysis examples: 6 worked from one dataset — 3 min read
• Real change or random noise? A plain guide to reading your numbers — 2 min read

Questions people ask

What is France's antiretroviral therapy coverage (% of people living with HIV)?

91% in 2022, according to the World Bank (World Development Indicators).

How has it changed since 2000?

It is up 15 percentage points from 76% in 2000. The highest value was 91% in 2022 and the lowest 76% in 2000.

Is the latest change in antiretroviral therapy coverage (% of people living with HIV) unusual for France?

In 2022, France's antiretroviral therapy coverage (% of people living with HIV) rose 1 percentage points on 2021 (from 90% to 91%). Across the 21 yearly changes before that (2001 to 2021), the average change was +0.67 percentage points and a typical year strayed about 0.66 percentage points from that (the standard deviation). This year's change was 0.5 standard deviations above that average, so it was an ordinary year: it sits within the range of normal year-to-year movement.

Source

World Bank, World Development Indicators, indicator SH.HIV.ARTC.ZS, licensed CC BY 4.0. Original source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), uri: https://aidsinfo.unaids.org/, publisher: UNAIDS, date accessed: 2025-08-27, date published: 2025-07 Figures are fetched from the World Bank API and refreshed monthly; see the series on data.worldbank.org. The full definition and method are in the World Bank's metadata glossary. Comparisons use the same World Bank release.

Want to ask your own questions of data like this? Try AnalyzeIt: upload a file or ask about public data in plain words, and every figure comes with its working.